Keyword: Sativex

THC/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study

Sativex as Add-on therapy Vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial

Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain

Cannabinoids for Treatment of Dystonia in Huntington’s Disease

Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial

Subjective and physiological effects after controlled Sativex and oral THC administration